Matcolin 2ml Injection contains Citicoline 250mg, a neuroprotective agent used to support cognitive function and enhance neurological recovery. Citicoline is a naturally occurring compound that serves as an intermediate in the biosynthesis of phosphatidylcholine, an essential component of neuronal cell membranes. This injectable formulation is indicated for the treatment of cognitive impairments associated with stroke, traumatic brain injury, and various neurodegenerative disorders. Matcolin promotes neuronal repair by enhancing membrane phospholipid synthesis, increasing cerebral metabolism, and improving neurotransmitter levels, particularly acetylcholine and dopamine. It also exhibits antioxidant properties that help reduce oxidative stress and neuronal damage. The 2ml injection is administered intramuscularly or intravenously, enabling rapid bioavailability and effective delivery to the central nervous system. Dosage and duration of therapy should be individualized based on clinical response and patient condition. Common adverse effects are generally mild and may include gastrointestinal disturbances, headache, or allergic reactions. Matcolin should be used cautiously in patients with hypersensitivity to citicoline or any excipients. It is contraindicated in individuals with known hypersensitivity to the active substance. This medication should be prescribed and administered under medical supervision to ensure optimal therapeutic outcomes and patient safety.